SEC Form 4 · accession 0000899243-17-018146
Seres Therapeutics, Inc. · MCRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Willard H Dere
Director
Period of report
Jul 7, 2017
Accepted (ET)
Jul 10, 2017 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609809
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.14 | Jul 7, 2017 | A | 30,000 | A | — | Jul 6, 2027 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The option will vest in four equal installments on each anniversary of 07/07/2017 or in full immediately prior to the occurrence of a change in control.